New Zealand’s competition enforcement and regulatory agency, The Commerce Commission, has now confirmed it will go ahead with an investigation into whether the resale voice services provided by the country’s largest telco, Spark, should be deregulated.
The Commission confirmed its decision on Thursday after completion of its five-yearly review of Schedule 1 of the Telecommunications Act 2001. The commission had released its draft preliminary finding in April, flagging that there were “reasonable grounds” to investigate removing Spark’s resale services.
Spark’s resale voice services have enabled retail service providers (RSPs) to offer retail fixed-line phone services without having to invest in their own infrastructure, with the services originally introduced with the Act in 2001 and subsequently amended in 2011.
Telecommunications commissioner Dr Stephen Gale said the Commission considered it was appropriate to take a closer look at deregulation of Spark’s services in light of “emerging competition from other wholesale alternatives”.
“As signalled in our draft decision, we believe Spark faces increased competition from other wholesale alternatives such as ultra-fast broadband and Chorus’ baseband services, which enable RSPs to provide retail voice services to consumers. Having considered submissions, in our view the time is right to investigate deregulation further.”
Full Content: ItWire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas